Background Pelvic lymph nodes metastasis is an important prognostic factor for patients with
cervical carcinoma. However, the relationships between the number of positive nodes, site …

Objective Patients with stage IB2 to IIA cervical cancer have a poor survival regardless of
what primary treatment is performed. We conducted a study to demonstrate whether …

The purpose of this study was to identify the prognostic factors for disease-free survival (DFS)
and recurrence patterns in Chinese women with squamous cell carcinoma of the vulva …

Dose-dense early postoperative intraperitoneal chemotherapy (DD-EPIC) significantly increased
non-progression rate in advanced ovarian cancer (OC) patients. We report final overall …

Background We assessed the efficacy of adding intraperitoneal (IP) chemotherapy to
standard first-line intravenous (IV) chemotherapy in epithelial ovarian cancer (EOC) patients. …

Abstract: Background and purpose: Over 80% of advanced ovarian cancer will recur after
primary treatment with a median progression-free survival time of 20 months. Patients with …

Objective: To investigate expression of proliferating cell nuclear antigen (PCNA) in ovarian
epithelial cancer and its relation to lymph node metastasis, outcome of second-look …

Methods The shrinkage of tumor and the radiation-induced damage were compared between
cervical squamous carcinoma and adenocarcinoma after twice afterloading radiotherapy. …

Objective: To investigate the significance of c-erbB-2 and PCNA expression in adenocarcinoma.
Methods: Expression of c-erbB-2 and PCNA in 74 cases of adenocarcinoma of the …

Objective To investigate the role of first-line chemotherapy in the management of advanced
epithelial ovarian cancer (AEOC) and the effects on long-term survival epithelial. Methods …